The 3rd Annual Evidence 360 Summit — RWE, Market Access & Pricing, hosted by Veridon Global, will take place on 11–12 March 2027 in Basel, Switzerland. It will bring together leading decision-makers representing pharma, biotech, RWE, HEOR, HTAs, payers, pricing & reimbursement groups, academia, and technology.
This year’s edition focuses on integrating an innovative approach to evidence generation and the access journey. Instead of treating RWE, HEOR, Market Access, and Pricing as isolated activities, we explore how they align across early development, launch, reimbursement, and post-launch evidence.
Key discussions will examine evolving European evidence requirements driven by changing HTA practices, demand for comparative real-world evidence, payer expectations, and value demonstration beyond clinical endpoints.